The past year for SRE has been anything but smooth. Looking at the chart, it's had some big swings dropped to about 74 last June, then a slow grind higher and a pretty strong October push. Since early spring, though, it's mostly been bouncing around this 90 96 zone. It's not running away, but it's not rolling over either.
I'm leaning bullish here, but not chasing it. There's a good defensive base utilities are still in demand with all the uncertainty around rates and economic growth, so SRE should keep benefitting from stable cash flows and rate base growth. Plus, their infrastructure investments look like they'll actually show up in earnings over the next couple of quarters. If they guide for steady dividend raises again at the next update, that should be a solid sentiment boost too.
That said, you can't ignore how quickly this stock rebounded from the fall lows. We're already up quite a bit in the last 12 months, so I'm not expecting fireworks. There's also the risk that if rates spike, SRE could retrace fast. If California or Texas hit them with new regulatory headaches, that's another possible drag.
I’m setting my target at 106.00 over the next 16 weeks. It's not a huge upside from here but feels reasonable given the recent trend and the sector. The next earnings call could be the main catalyst especially if they lift guidance or talk up their project pipeline. Keeping my bets small and my stop tight, but this looks like one of the steadier setups in utilities right now.
DOCU looks like it's been through the wringer the last year. From a high in the low 80s just last fall to the mid 40s a few months ago, then a bounce back above 50. That kind of price action usually means mixed confidence, and frankly, it's not hard to see why. The market really rerated the stock after a string of disappointing quarters and the general sentiment shift around SaaS companies that aren't showing dramatic growth.
I'm leaning cautiously bullish here, though not because I think DOCU is about to rip back to old highs, but because it finally looks like expectations have come back to earth. At 47.26, a lot of pessimism seems priced in. The core product is still sticky with enterprise, and they do have a moat around compliance and integration even if the "e signature" playbook feels a bit tired. If management can demonstrate any sustained margin improvement in the next quarter, there should be room for a relief rally.
My target's 56.50 in the next 10 weeks. That's about a 20 percent move from here, which seems realistic as a near term catch up trade if DOCU can string together a couple of decent updates and avoid any more negative surprises. The risk is that growth keeps slowing, or that churn ticks up and investors see DOCU as dead money. If one more quarter misses, this could easily drift back toward the mid 40s or even lower.
The catalyst I'm watching is next earnings if they can beat (or at least meet) and show that enterprise contracts are holding, that could be enough for a short term re rating. I'm not going in heavy, but the risk/reward finally looks reasonable after such a brutal reset.
Looking at BLK’s chart from the past year, you can’t ignore how choppy things have been. It ran from just under 985 last June all the way up to around 1166 in October, then faded and has spent a lot of time bouncing between 970 and 1130 since. Right now at 1022.56, we’re right around the midpoint of that range. I’m leaning cautiously bullish here, but I’m not calling for fireworks.
This is still BlackRock. They’re the asset manager of record, and with rates steady or even inching down later in the year, flows into ETFs and fixed income should help out. What stands out is the stickiness of their AUM even with macro headwinds, plus their cost discipline. They’re not immune to market cycles, but the base business is consistent.
My target’s 1180.00 in the next 20 weeks. That’s a bit below last fall’s high. I’m not banking on multiple expansion, just a return to the upper end of the trading range if the markets stay constructive and inflows pick up with a Fed cut, or just some better guidance from management. There’s no massive upside surprise baked in, I just think the risk reward at this level is decent for a conservative play.
The main risk I see is a real correction in equities. If we see anything like a major risk off move or a sharp drop in global markets, BLK will go with it. Also, any hiccups on asset flows or regulatory headaches could knock them down fast. I’m keeping an eye on their next earnings call as a near term catalyst if they talk up inflows or expense control, that could be enough to push it toward my target.
Looking at AMZN lately, it's hard not to notice how choppy the ride has been. Not all that long ago it was hanging around the low 200s, dipping down to $198.79 in mid February before slowly crawling its way back up. Lately, at $266.32, it’s close to the recent high, so I’m definitely not pounding the table here. Still, I’m leaning cautiously bullish, targeting $290.00 over the next couple months. That's not a moonshot, just a measured move up.
There’s a couple things I think are working in Amazon’s favor. Retail is chugging along, but AWS growth feels like it’s picking up speed again. With cloud spend stabilizing, there’s a case for margin expansion if they keep costs in check. Also, advertising is quietly becoming a bigger chunk of revenue, and that’s been a positive surprise for a while now. I wouldn’t ignore the fact that management’s been tighter with expenses lately either, especially after some wobbly quarters last year.
I can’t shake the risk that consumer spending slows into the back half of the year. If there’s even a mild recession or further softness in e commerce, AMZN will get knocked just like everyone else. The stock’s already run a lot since mid April, so a pullback would not shock me. That’s why I wouldn’t chase it if it spikes past $270 without a meaningful catalyst.
I’ll be watching next quarter’s earnings for any signs that cloud growth is more sustainable, or for new numbers on ad revenue. If they show another clean beat and raise, that could keep the momentum going. But all things considered, I’m sticking to a modest upside. Not an all in moment, but I like the risk reward at these levels if you size it right.
KMB has been in rough shape lately. Just looking at the price action over the past year, the stock went from above 140 to under 100. That's a pretty big slide for something like Kimberly Clark, which is usually seen as a safe, stable name. Lately it's been bouncing around the high 90s, and that price is starting to look much more reasonable after all this selling pressure.
I'm not going to call a massive rebound here, but I am leaning slightly bullish at these levels. The main thing for me is that the current price bakes in a lot of pessimism about volumes and margin pressure. With cost cutting and some stabilization in input costs, I think there's room for KMB to grind back to around 110.00 over the next few months. The dividend is still pretty solid, and the business isn't going away just because of a bad year. People are still going to buy the core products no matter what the economy does.
The biggest risk is that things stay ugly for longer, and any sort of demand recovery just doesn't materialize this year. If consumer headwinds stick around or input costs spike again, the stock could just drift sideways or even keep leaking lower. I don't see a lot of upside if the next couple quarters come in soft.
Upcoming earnings could be a catalyst for some re rating if they can show that margins are improving or guide a little better. I wouldn't expect fireworks, but even a small beat could be enough to get this back into the low 100s. Not the most exciting play, but I think the reward is starting to outweigh the risk for patient holders.
EBAY's run over the past year has honestly surprised me a bit. If you look at the chart, it's had a pretty steady climb from the low 70s up to where we're sitting now around 117.13. The jump from August onward was especially sharp, but it feels like it's getting ahead of itself at this point. I’m leaning bearish here and setting my target at 99.00 for the next few months.
The main thing that's nagging at me is how stretched the valuation looks compared to the actual growth. eBay still has the brand and some loyal users, but they're not really outpacing competitors in any meaningful way. The secondhand and collectibles categories are solid but not growing like they used to, and new upstarts keep chipping away at market share. Plus, costs for acquiring new sellers are creeping up, and that eats into margins quick.
Another worry: if consumer spending takes any kind of hit, discretionary platforms like EBAY could see volumes drop pretty fast. That's not a prediction, just something that feels underappreciated with how optimistic the recent run has been. I could definitely see a pullback, at least down to the low 100s, before any new leg up so 99.00 is my base case right now.
I’ll watch their next earnings closely. If they show real margin improvement or finally get traction on some of the newer categories, that could change the story fast. But for now, risk/reward looks tilted to the downside from here.
PSA's been all over the place this past year. Just looking at the price history, it's had some pretty sharp moves from the low 260s to well above 300, and plenty of back and forth in between. Right now at 292.47, it's not at the lows but also not pushing new highs, so I don't see this as stretched or screaming value either way.
I'm leaning bearish for the next few months. Rates look stubborn, which keeps pressure on REITs like PSA, and the volatility in the chart doesn't give me tons of confidence that the market's settled on a stable range for these guys. Plus, self storage demand isn't exactly going gangbusters consumer softness and higher move out rates are showing up in earnings across the space. Not a disaster, just a drag on growth for now.
If they guide down on occupancy or cut FFO outlook in the next earnings call, I think we could revisit the 265.00 level. That's my target. I see at least a few weeks of chop or grind down unless something changes on the macro side or they surprise with an aggressive buyback or asset sale.
The wild card is if the Fed signals a real pivot or interest rates fall meaningfully. That could flip the script quick. But for now, PSA's last few months show that the floor can drop out fast if sentiment sours. I wouldn't get cute trying to time the absolute bottom, but I don't like the risk/reward up here.
LOW’s price action over the past year has been all over the place. It touched what looked like a peak near 278 back in February, then sold off hard, and here we are near 218. That’s a pretty steep drawdown for a name you’d expect to be a bit steadier. My base case is bullish, but it’s not a high conviction call. I’m looking for a recovery to about 255.00 in the next few months, not a rip back to all time highs.
First, I think a lot of the negativity is already baked in. The last few earnings have cleared the deck on inventory and demand worries. Home improvement spend is still soft compared to pandemic levels, but not falling off a cliff. If mortgage rates start to ease by year end, you could see DIY return and some light pro activity tick up. LOW is still a solid operator even if comps are negative, and it’s been buying back shares regularly. It’s not exciting, but it’s not a value trap.
If I had to pick a catalyst, it would probably be the fall earnings update or, maybe more likely, a slight guide up on full year margins. LOW has been pretty conservative, so a little bit of good news could move the stock. The trouble is, it’s not immune to any fresh macro shocks. If rates stay sticky or we see another leg down in housing, LOW could easily chop along at these levels or worse.
This isn’t a set and forget play. Risk is that the housing cycle is just stuck for much longer and you end up bagholding a sideways stock. But with the recent selloff, the risk reward is a lot more balanced than it was at 270+.
TRV has been on a pretty steady climb if you zoom out just look at the last year. There’s a lot of back and forth, but from the summer lows around 252, we’re sitting much closer to 300 now. Not saying it’s been a smooth ride, but insurance stocks rarely are. I’m not ready to call it a breakout just yet though. My stance here is moderately bullish, but with guardrails.
The main reason for optimism is that Travelers really seems to be navigating the higher claims environment better than most. Their combined ratio has stayed in check, and they’ve quietly been hiking premiums where they can. On top of that, investment income is ticking up with rates where they are. That’s an underrated lever for these guys. I see a 318.00 target as achievable if they keep this up nothing crazy, but about a 20 point move from here.
The risk is always weather. One ugly hurricane season and you get an earnings mess fast. There’s also the possibility that the market is already pricing in a soft landing and some of those investment gains start to flatten if rates drop.
Next catalyst is the Q2 earnings call coming up in about 8 weeks. That’ll tell us if claims inflation is really under control or if we’re just getting lucky. Until then, I’m holding but with an eye on the exits if volatility picks up.
Looking at CVS right now, I'm leaning slightly bullish, but honestly not by much. The stock's had a pretty turbulent year, swinging from about 60 up to where it is now at 86.86. That last six months really stand out lots of chop between 60 and 80, but lately it's climbed back, and I don’t think it’ll run away from here. I’m setting my target at 95.00 in the next four to five months. It’s a modest upside, nothing wild.
The main thing keeping me interested is their broad reach in healthcare, especially with the mix of retail, pharmacy benefit management, and insurance. Even in a tough macro, those segments should provide some cushion. The company’s cost cutting efforts have started to show up in recent quarters, helping stabilize earnings after some ugly misses last year. If they can keep expenses controlled, there’s a decent shot at steady improvement from here.
I’m cautious though. Competition is intense both from traditional pharmacy chains and bigger online players. The risk here is any slip up on reimbursement rates or regulatory pressure could knock this right back to where it was in early 2025. Also, the market has clearly been nervous before, judging by those big dips (like that drop to 60 in May).
The next big thing to watch is their Q2 report. If CVS can show consistent progress on margins and maybe guide a bit higher on full year earnings, that should push sentiment up enough to reach my 95.00 target. But I wouldn’t be shocked if it stalls out for a bit either the market’s still a little jittery around these old school healthcare names.
